Approval · Notice of Compliance 6846 · 1998
MYSOLINE PRIMIDONE TABLETS: Notice of Compliance 6846
Issued April 17, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6846
- Date
- April 17, 1998
- Company
- Ayerst Veterinary LaboratoriesGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anticonvulsant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYSOLINE PRIMIDONE TABLETS | 00002631 | — |
Medicinal ingredients
- PRIMIDONE 250 MG per TAB